publication date: Nov 13, 2013
|
author/source: Kapler Communications Ltd
ModiQuest Research BV, the Dutch antibody generation services company, today announced that it has entered into a research collaboration with the Beckman Research Institute of the City of Hope (“BRICOH”) aimed at the generation of novel monoclonal antibodies against a target selected by and proprietary to BRICOH.
During the collaboration, ModiQuest will make use of its proprietary B-cell selection technology, ModiSelectTM. Financials details of the collaboration were not disclosed.
“We are delighted that the Beckman Research Institute of the City of Hope has selected ModiQuest Research as an antibody generation collaborator,” said Dr. Jos Raats, Managing Director of ModiQuest Research. “This collaboration again demonstrates the value of our broad and unique technology platform for finding monoclonal antibodies against some of the most difficult antigen targets.”
more about ModiSelect
more about ModiQuest Research
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.